Information

GelStat Corporation ("GelStat" or "Company") is a publicly traded company trading under the symbol ("GSAC") that is engaged in research, development and marketing of innovative over-the-counter (OTC) consumer healthcare products. Most OTC products available today are based on decades-old formulations and technologies. GelStat’s goal is to combine innovative formulations with uniquely advantageous delivery systems to develop a portfolio of proprietary products with improved efficacy, safety, and/or convenience.

The Company's first product, GelStat™ Migraine is currently available direct-to-consumer and through numerous retailers nationwide. Equally important, GelStat has a number of additional products in its pipeline including GelStat™ Sleep and GelStat™ Arthritis.  Each of these products offer consumers healthy alternatives to traditional treatments and address very large markets.

GelStat intends to capitalize on these markets by combining innovative formulations with uniquely advantageous delivery systems to provide consumers with clinically proven products that have improved efficacy, safety and convenience. In line with this strategy, two clinical trials have been conducted on GelStat™ Migraine, both yielding positive results.